TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29219895

Group type: EXPERIMENTAL
Intervention: Resistance training (RES)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 21
Study: 28759977

Group type: EXPERIMENTAL
Intervention: Progressive backward body weight‐supported treadmill training
Number of subjects: 30

Group type: COMPARATOR
Intervention: General treadmill gait training (control)
Number of subjects: 30
Study: 26148997

Group type: EXPERIMENTAL
Intervention: Laparoscopic hepatectomy (LH)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open hepatectomy (OH)
Number of subjects: 100
Study: 23331421

Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Menthol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study: 22029547

Group type: EXPERIMENTAL
Intervention: 10 week stepped activity programme (activity diary, dance DVD, circuit-training, motivational interviewing)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Control schools (not specified in detail)
Number of subjects: 396
Study: 19395275

Group type: EXPERIMENTAL
Intervention: ClosureFAST (RF thermal ablation)
Number of subjects: 69

Group type: COMPARATOR
Intervention: 980-nm EVL (endovenous laser ablation)
Number of subjects: 69
Study: 16894099

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 333
Study: 15315998

Group type: EXPERIMENTAL
Intervention: Supervised physical therapy and exercise training (n = 46)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Home exercise (control condition; n = 44)
Number of subjects: 90
Study: 11293458

Group type: EXPERIMENTAL
Intervention: Segmentation of videos into coarse and fine units with simultaneous description
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Describing from memory rather than perception
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Descriptions were telegraphic and without communicative intent
Number of subjects: 0
Study: 9471092

Group type: EXPERIMENTAL
Intervention: Intervention involving teaching refusal skills to adolescents
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 2000
Study: 7932336

Group type: EXPERIMENTAL
Intervention: Patients with dyspeptic cholelithiasis (Group 2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Patients with dyspepsia after cholecystectomy (Group 4)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Patients with no dyspepsia after cholecystectomy (Group 3)
Number of subjects: 48
Study: 30810638

Group type: EXPERIMENTAL
Intervention: GTP (periodontal and peri-implant maintenance therapy)
Number of subjects: 80

Group type: COMPARATOR
Intervention: GNTP (no regular maintenance)
Number of subjects: 80
Study: 30190749

Group type: EXPERIMENTAL
Intervention: Core stability exercise
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional exercise
Number of subjects: 62
Study: 26595937

Group type: EXPERIMENTAL
Intervention: DVD-delivered exercise intervention
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: GLTEQ scores
Number of subjects: 238
Study: 24279801

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 22596206

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 49

Group type: COMPARATOR
Intervention: THC
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: THC with olanzapine
Number of subjects: 49
Study: 20557509

Group type: EXPERIMENTAL
Intervention: Trigonometric method (TM) of radiographic analysis
Number of subjects: 51

Group type: COMPARATOR
Intervention: Goniometer method (GM)
Number of subjects: 51
Study: 17707091

Group type: EXPERIMENTAL
Intervention: Immunomodulatory therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 15943840

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg twice daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Famotidine and Omeprazole
Number of subjects: 54
Study: 12808175

Group type: EXPERIMENTAL
Intervention: Polysulphone filter HD
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cuprophane filter HD
Number of subjects: 12
Study: 10492157

Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg daily for 2 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ranitidine (150 mg daily for 21 days)
Number of subjects: 10
Study: 8697718

Group type: EXPERIMENTAL
Intervention: Facial cooling
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Breath-hold in expiration combined with facial cooling
Number of subjects: 45
Study: 1766707

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 89

Group type: COMPARATOR
Intervention: Ceftazidime plus vancomycin
Number of subjects: 89
Study: 6752878

Group type: EXPERIMENTAL
Intervention: Pirprofen 200 mg four times a day
Number of subjects: 342

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 900 mg four times a day
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Pirprofen
Number of subjects: 342

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 342
Study: 31433895

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided dorsal penile nerve block
Number of subjects: 33

Group type: COMPARATOR
Intervention: Neurostimulator-guided pudendal nerve block
Number of subjects: 33
Study: 29929495

Group type: EXPERIMENTAL
Intervention: Brief multifamily psychoeducation (BMP)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (one counseling session administered by a nurse)
Number of subjects: 49
Study: 27543828

Group type: EXPERIMENTAL
Intervention: Occupational Goal Intervention (OGI)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Craft activities (control)
Number of subjects: 25
Study: 25251794

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: No massage (control)
Number of subjects: 30
Study: 23327030

Group type: COMPARATOR
Intervention: bupivacaine + fentanyl (7.5 mg of 0.5% bupivacaine + 15 microg fentanyl intrathecally)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: levobupivacaine + fentanyl (7.5 mg of 0.5% levobupivacaine + 15 microg fentanyl intrathecally)
Number of subjects: 50
Study: 20039889

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg daily
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 18786043

Group type: EXPERIMENTAL
Intervention: Asthma education delivered by lay health educators (LHEs)
Number of subjects: 183

Group type: COMPARATOR
Intervention: General health promotion education (attention-control condition)
Number of subjects: 183
Study: 16258155

Group type: EXPERIMENTAL
Intervention: Real-time polymerase chain reaction (PCR) assay targeting 16S rDNA, limit of detection: 40, 50, or 2000 CFU/ml for E. coli, group B Streptococcus, and Listeria monocytogenes respectively, sample preparation and PCR duration less than 4 hours.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Culture-based methods for diagnosing neonatal sepsis, duration 1 to 2 days for growth detection, 5 days for no-growth results.
Number of subjects: 85
Study: 12518175

Group type: EXPERIMENTAL
Intervention: Nerve blocks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Cognitive therapy
Number of subjects: 68
Study: 9951493

Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (TA) 75 mg/kg per day divided into 3 doses
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Oral prednisolone 0.75 mg/kg per day divided into 2 doses
Number of subjects: 238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study: 7591596

Group type: EXPERIMENTAL
Intervention: Doxazosin (4 mg/day) for 72 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Prazosin (4 mg/day) for 24 weeks
Number of subjects: 64
Study: 2309643

Group type: EXPERIMENTAL
Intervention: Supplemental feeding from birth to age 36 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (unsupplemented)
Number of subjects: 0
Study: 6246006

Group type: EXPERIMENTAL
Intervention: Mecillinam alone or in combination with ampicillin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ampicillin alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mecillinam (5 mg/kg intravenously every six hours)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mecillinam (10 mg/kg intravenously every six hours)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combined therapy (mecillinam and ampicillin)
Number of subjects: 20
Study: 31074244

Group type: EXPERIMENTAL
Intervention: Nivolumab (PD-1 inhibitor) administered every second week until disease progression
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nivolumab (PD-1 inhibitor)
Number of subjects: 18
Study: 30201024

Group type: EXPERIMENTAL
Intervention: BHH10
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 27125883

Group type: EXPERIMENTAL
Intervention: Mixed fibre (5 g b.d. for 4 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Psyllium (5 g b.d. for 4 weeks)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Mixed fibre
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Mixed fibre and psyllium
Number of subjects: 72
Study: 25453515

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 12
Study: 23448082

Group type: EXPERIMENTAL
Intervention: New specially engineered sonic powered toothbrush
Number of subjects: 184

Group type: COMPARATOR
Intervention: Commercially available toothbrushes
Number of subjects: 184
Study: 20490392

Group type: EXPERIMENTAL
Intervention: Esthet‐X Flow
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Tetric Flow
Number of subjects: 63

Group type: COMPARATOR
Intervention: Both materials
Number of subjects: 63
Study: 18931210

Group type: EXPERIMENTAL
Intervention: Vein Entry Indicator Device (VEID)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control (standard peripheral venous cannulation)
Number of subjects: 202
Study: 15531619

Group type: EXPERIMENTAL
Intervention: Airflow via sponge-tipped oxygen catheter at a rate of 115 ml kg(‐1) min(‐1) for 6 hours
Number of subjects: 15

Group type: COMPARATOR
Intervention: No airflow for 6 hours (control)
Number of subjects: 15
Study: 12953342

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg qid for 3 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen 500 mg bid for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg qid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen 500 mg bid
Number of subjects: 0
Study: 10971231

Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg b.d., clarithromycin 500 mg b.d., and metronidazole 500 mg b.d. (PCM)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: pantoprazole 40 mg b.d., amoxycillin 1000 mg b.d., and clarithromycin 500 mg b.d. (PAC)
Number of subjects: 331
Study: 9011466

Group type: COMPARATOR
Intervention: 3 MU interferon-alpha2b every two days for another six months (group A, total dose: 410 MU)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Increasing doses of interferon-alpha2b (6 MU every two days for three months, followed by 10 MU every two days for three months) (group B, total dose: 870 MU)
Number of subjects: 138

Group type: COMPARATOR
Intervention: 3 MU interferon-alpha2b every two days for three months (initial treatment)
Number of subjects: 138
Study: 1434681

Group type: EXPERIMENTAL
Intervention: Zea mays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imperata cylindrica
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plantago major
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthosiphon stamineus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3873614

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 160

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 160
Study: 30696903

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine with higher dosage and extended schedule (four monthly doses)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Standard dosage of dihydroartemisinin-piperaquine
Number of subjects: 179
Study: 27836982

Group type: EXPERIMENTAL
Intervention: WEB+SN+NRT
Number of subjects: 5290

Group type: EXPERIMENTAL
Intervention: WEB+SN
Number of subjects: 5290

Group type: EXPERIMENTAL
Intervention: WEB+NRT
Number of subjects: 5290

Group type: COMPARATOR
Intervention: WEB
Number of subjects: 5290
Study: 26454450

Group type: EXPERIMENTAL
Intervention: Make a Wish intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 66
Study: 24099152

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg/day
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Moxonidine 0.6 mg/day
Number of subjects: 112
Study: 22687174

Group type: EXPERIMENTAL
Intervention: Personal meta-stereotype manipulations (your partner thinks you are biased)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General threat condition
Number of subjects: 0
Study: 19367282

Group type: EXPERIMENTAL
Intervention: Lomeguatrib 40 mg, b.i.d. for 10 days with temozolomide 75 mg m(‐2) on days 1‐5
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lomeguatrib extended dosing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lomeguatrib with temozolomide
Number of subjects: 32
Study: 17441794

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study: 15823785

Group type: EXPERIMENTAL
Intervention: Imaginative and hypnotic suggestions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Placebo (administered after suggestions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 60
Study: 12516678

Group type: EXPERIMENTAL
Intervention: Sonicare Elite toothbrush
Number of subjects: 25

Group type: COMPARATOR
Intervention: Manual toothbrush (Oral-B 35)
Number of subjects: 25
Study: 9595919

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 50 micrograms/day for three weeks with MAP 10 mg orally for 10 days
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 7700744

Group type: EXPERIMENTAL
Intervention: 3-week multifaceted AIDS education program
Number of subjects: 189
Study: 2403699

Group type: EXPERIMENTAL
Intervention: Platelet-derived wound healing formula (PDWHF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Platelet-derived wound healing formula (PDWHF) after crossover
Number of subjects: 32
Study: 678495

Group type: EXPERIMENTAL
Intervention: 3.0% levamisole solutions
Number of subjects: 4

Group type: COMPARATOR
Intervention: 3.0% mebendazole suspensions
Number of subjects: 4

Group type: COMPARATOR
Intervention: 0.03% DEC
Number of subjects: 4
Study: 30641807

Group type: EXPERIMENTAL
Intervention: Diabetes Comprehensive Care Model (DCCM) intervention implemented by mobile diabetes care teams, four times over one year.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual (control group).
Number of subjects: 100
Study: 29068977

Group type: EXPERIMENTAL
Intervention: GlideScope (GS) video laryngoscope
Number of subjects: 45

Group type: COMPARATOR
Intervention: CTrach laryngeal mask airway (LMA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Shikani optical stylet rigid laryngoscope (SOS)
Number of subjects: 45
Study: 25865433

Group type: EXPERIMENTAL
Intervention: Improved body image
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Higher exercise intrinsic motivation
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: High exercise autonomous motivation
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Lower perceived exercise barriers among women with lower autonomous motivation
Number of subjects: 154
Study: 25158710

Group type: EXPERIMENTAL
Intervention: High-dose-rate brachytherapy (2 × 6 Gy administered in two fractions: first within 4 hours after surgery and second within 24 hours)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: High-dose-rate brachytherapy
Number of subjects: 43
Study: 22067244

Group type: COMPARATOR
Intervention: Control Condition (CC) - 5 minutes of passive rest
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Passive Stretching Condition (PSC) - 5 minutes of passive static stretching
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Active Stretching Condition (ASC) - 5 minutes of active static stretching
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching Condition (DC) - 5 minutes of dynamic stretching
Number of subjects: 16
Study: 19486654

Group type: EXPERIMENTAL
Intervention: Possible clinical depression at initial PSA testing (n=519)
Number of subjects: 4886

Group type: COMPARATOR
Intervention: Initial psychological distress scores
Number of subjects: 4886
Study: 17306006

Group type: EXPERIMENTAL
Intervention: S. boulardii
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 15381932

Group type: EXPERIMENTAL
Intervention: 350 mg m(‐2) irinotecan as a 90‐min i.v. infusion q3 weeks (Arm A)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: 125 mg m(‐2) irinotecan as a 90‐min i.v. infusion weekly x 4 weeks q6 weeks (Arm B)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: 250 mg m(‐2) irinotecan as a 90‐min i.v. infusion q2 weeks (Arm C)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: 10 mg m(‐2) day(‐1) irinotecan as a 14‐day continuous infusion q3 weeks (Arm D)
Number of subjects: 174
Study: 11118782

Group type: EXPERIMENTAL
Intervention: Systematic education using a self‐conducted, interactive Kodak Photo‐CD program plus personal drug information and non‐commercial drug leaflets.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional information (Control group).
Number of subjects: 0
Study: 9829706

Group type: EXPERIMENTAL
Intervention: DFMO 0.5 g/m2/day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: DFMO
Number of subjects: 45
Study: 7510330

Group type: EXPERIMENTAL
Intervention: Isoprinosine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 2687688

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg every six hours)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7456815

Group type: EXPERIMENTAL
Intervention: Pre- and postoperative substitution of factor XIII
Number of subjects: 95
Study: 31904995

Group type: EXPERIMENTAL
Intervention: Energy-dense nutrition (1.5 kcal/ml)
Number of subjects: 3957

Group type: COMPARATOR
Intervention: Routine enteral nutrition (1.0 kcal/ml)
Number of subjects: 3957

Group type: EXPERIMENTAL
Intervention: Energy-dense nutrition
Number of subjects: 3957
Study: 30513266

Group type: EXPERIMENTAL
Intervention: Alcohol skin cleansing (swab group)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (cleansed adjacent to injection site)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both groups (swab and control)
Number of subjects: 170
Study: 27670267

Group type: COMPARATOR
Intervention: Trisodium citrate 30% (TSC)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Minocycline 3 mg/mL plus EDTA 30 mg/mL (M-EDTA)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Heparin 1000 IU/mL (H)
Number of subjects: 75
Study: 26370664

Group type: EXPERIMENTAL
Intervention: Intrauterine contraception (IUD) provided immediately after surgical abortion (18.1%) or at follow-up 2-4 weeks after medical abortion (81.9%).
Number of subjects: 751

Group type: COMPARATOR
Intervention: Oral contraceptives prescribed to the control group with follow-up visit advised.
Number of subjects: 751
Study: 23701492

Group type: EXPERIMENTAL
Intervention: Brisk walking with graduated compression stockings (GCSs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Brisk walking without graduated compression stockings (CON trial)
Number of subjects: 10
Study: 22308853

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH)
Number of subjects: 48
Study: 19056550

Group type: EXPERIMENTAL
Intervention: [6S]‐5‐methylTHF (416 microg/d, 906 nmol/d)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Folic acid (400 microg/d, 906 nmol/d)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 18380203

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Topical 20% aluminum chloride (AC)
Number of subjects: 25
Study: 15383083

Group type: EXPERIMENTAL
Intervention: Chronotropic incompetence (CI) defined as a failure to achieve 80% of heart rate reserve (%HRR)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Lower body mass index (BMI < 16 kg m(‐2), n = 14)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Daytime HRV parameters reflecting the sympathetic autonomic equilibrium (LF nu, LF/HF ratio)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 22
Study: 11324651

Group type: EXPERIMENTAL
Intervention: Vocal Function Exercises (VFE)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Vocal Hygiene (VH)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 58
Study: 9075480

Group type: EXPERIMENTAL
Intervention: p24-VLP (500 or 1,000 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: p24-VLP (highest dose)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: p24-VLP
Number of subjects: 8
Study: 8396320

Group type: EXPERIMENTAL
Intervention: Oral acyclovir, 800 mg four times daily
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oral acyclovir, 800 mg four times daily + IVIG, 300 mg/kg every 2 weeks for six doses
Number of subjects: 21

Group type: COMPARATOR
Intervention: Ganciclovir
Number of subjects: 21
Study: 3530643

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (400 micrograms)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (200 micrograms)
Number of subjects: 18
Study: 11280632

Group type: EXPERIMENTAL
Intervention: Intracatheter nitroglycerin (NTG) infusion at 0.1 mcg x kg x min in 5% dextrose
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group receiving only 5% dextrose
Number of subjects: 44